First-in-human study of the safety, pharmacokinetics, and pharmacodynamics of first-in-class fatty acid synthase inhibitor TVB-2640 alone and with a taxane in advanced tumors - ScienceDirect
By A Mystery Man Writer
Description
![First-in-human study of the safety, pharmacokinetics, and pharmacodynamics of first-in-class fatty acid synthase inhibitor TVB-2640 alone and with a taxane in advanced tumors - ScienceDirect](https://www.natap.org/2021/images/112021/112021-2/1120212.gif)
Novel, first-in-class, fatty acid synthase inhibitor, TVB-2640
![First-in-human study of the safety, pharmacokinetics, and pharmacodynamics of first-in-class fatty acid synthase inhibitor TVB-2640 alone and with a taxane in advanced tumors - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0753332223013896-gr1.jpg)
Targeting fatty acid uptake and metabolism in cancer cells: A
![First-in-human study of the safety, pharmacokinetics, and pharmacodynamics of first-in-class fatty acid synthase inhibitor TVB-2640 alone and with a taxane in advanced tumors - ScienceDirect](https://www.frontiersin.org/files/myhome%20article%20library/496787/496787_Thumb_400.jpg)
Frontiers First-In-Human Study to Assess the Safety
![First-in-human study of the safety, pharmacokinetics, and pharmacodynamics of first-in-class fatty acid synthase inhibitor TVB-2640 alone and with a taxane in advanced tumors - ScienceDirect](https://minio.scielo.br/documentstore/1678-2690/3K38r6DKNXG8VNhvnSrHxMQ/749f0d9903663b3b90b7c4fe089784f84add1c56.jpg)
SciELO - Brasil - Fatty acid synthase as a potential new
![First-in-human study of the safety, pharmacokinetics, and pharmacodynamics of first-in-class fatty acid synthase inhibitor TVB-2640 alone and with a taxane in advanced tumors - ScienceDirect](https://www.frontiersin.org/files/Articles/497662/fonc-09-01412-HTML-r1/image_m/fonc-09-01412-g002.jpg)
Frontiers Pathogenetic, Prognostic, and Therapeutic Role of
![First-in-human study of the safety, pharmacokinetics, and pharmacodynamics of first-in-class fatty acid synthase inhibitor TVB-2640 alone and with a taxane in advanced tumors - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0753332223015391-gr2.jpg)
Acetyl-CoA metabolism as a therapeutic target for cancer
![First-in-human study of the safety, pharmacokinetics, and pharmacodynamics of first-in-class fatty acid synthase inhibitor TVB-2640 alone and with a taxane in advanced tumors - ScienceDirect](https://ars.els-cdn.com/content/image/3-s2.0-B9780128240434000075-f05-02-9780128240434.jpg)
The role of fatty acids metabolism on cancer progression and
![First-in-human study of the safety, pharmacokinetics, and pharmacodynamics of first-in-class fatty acid synthase inhibitor TVB-2640 alone and with a taxane in advanced tumors - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0169409X20300971-ga1.jpg)
Lipids and cancer: Emerging roles in pathogenesis, diagnosis and
![First-in-human study of the safety, pharmacokinetics, and pharmacodynamics of first-in-class fatty acid synthase inhibitor TVB-2640 alone and with a taxane in advanced tumors - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0223523422005153-gr5.jpg)
Emerging roles of fatty acid metabolism in cancer and their
![First-in-human study of the safety, pharmacokinetics, and pharmacodynamics of first-in-class fatty acid synthase inhibitor TVB-2640 alone and with a taxane in advanced tumors - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2589537021000778-gr1.jpg)
First-in-human study of the safety, pharmacokinetics, and
![First-in-human study of the safety, pharmacokinetics, and pharmacodynamics of first-in-class fatty acid synthase inhibitor TVB-2640 alone and with a taxane in advanced tumors - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0753332223013896-ga1.jpg)
Targeting fatty acid uptake and metabolism in cancer cells: A
![First-in-human study of the safety, pharmacokinetics, and pharmacodynamics of first-in-class fatty acid synthase inhibitor TVB-2640 alone and with a taxane in advanced tumors - ScienceDirect](https://minio.scielo.br/documentstore/1678-2690/3K38r6DKNXG8VNhvnSrHxMQ/a165e54815b096e8e0e87885da378e9b32eaec68.jpg)
SciELO - Brasil - Fatty acid synthase as a potential new
![First-in-human study of the safety, pharmacokinetics, and pharmacodynamics of first-in-class fatty acid synthase inhibitor TVB-2640 alone and with a taxane in advanced tumors - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0016508521032765-gr4.jpg)
TVB-2640 (FASN Inhibitor) for the Treatment of Nonalcoholic
![First-in-human study of the safety, pharmacokinetics, and pharmacodynamics of first-in-class fatty acid synthase inhibitor TVB-2640 alone and with a taxane in advanced tumors - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0304383523003038-gr3.jpg)
Fatty acids in cancer chemoresistance - ScienceDirect
from
per adult (price varies by group size)